Dissemination and genome analysis of high-level ceftriaxone-resistant penA 60.001 Neisseria gonorrhoeae strains from the Guangdong Gonococcal antibiotics susceptibility Programme (GD-GASP), 2016-2019

Background: After Neisseria gonorrhoeae FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate increased remarkably. Epidemiological investigations are greatly significant for the analysis of antimicrobial resistance (AMR) trends, mole...

Full description

Saved in:
Bibliographic Details
Published inEmerging microbes & infections Vol. 11; no. 1; pp. 344 - 350
Main Authors Lin, Xiaomian, Chen, Wentao, Xie, Qinghui, Yu, Yuqi, Liao, Yiwen, Feng, Zhanjin, Qin, Xiaolin, Wu, Xingzhong, Tang, Sanmei, Zheng, Heping
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 01.12.2022
Taylor & Francis Ltd
Taylor & Francis Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background: After Neisseria gonorrhoeae FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate increased remarkably. Epidemiological investigations are greatly significant for the analysis of antimicrobial resistance (AMR) trends, molecular features and evolution. Objectives: To clarify the AMR trend from 2016-2019 and reveal the molecular characteristics and evolution of ceftriaxone-resistant penA 60.001 isolates. Methods: The minimum inhibitory concentrations (MICs) of antibiotics against 4113 isolates were detected by the agar dilution method. N. gonorrhoeae multiantigen sequence typing (NG-MAST), multilocus sequence typing (MLST) and N.gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) were used to identify the sequence types. Genome analysis was conducted to analyze resistance genes, virulence factors, and evolutionary sources. Results: Isolates with decreased ceftriaxone susceptibility have increased from 2.05% (2016) to 16.18% (2019). Six ceftriaxone-resistant isolates possessing penA 60.001 appeared in Guangdong Province, and were resistant to ceftriaxone, penicillin, tetracycline, ciprofloxacin and cefixime, but susceptible to azithromycin and spectinomycin. Single-nucleotide polymorphisms (SNPs) in the porB gene were the major cause of different NG-MAST types. ST1903 was the main NG-STAR genotype and only strain-ZH545 was ST7365, with molecular features consistent with the MICs. Furthermore, different MLSTs suggested diverse evolutionary sources. Genome analysis revealed a set of virulence factors along with the resistance genes "penA" and "blaTEM-1B". Half of penA 60.001 strains were fully mixed with global FC428-related strains. Conclusions: Global FC428-related clones have disseminated across Guangdong, possibly causing decreased ceftriaxone susceptibility. Enhanced gonococcal surveillance will help elucidate the trajectory of transmission and curb further dissemination.
AbstractList After FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate increased remarkably. Epidemiological investigations are greatly significant for the analysis of antimicrobial resistance (AMR) trends, molecular features and evolution. To clarify the AMR trend from 2016-2019 and reveal the molecular characteristics and evolution of ceftriaxone-resistant 60.001 isolates. The minimum inhibitory concentrations (MICs) of antibiotics against 4113 isolates were detected by the agar dilution method. multiantigen sequence typing (NG-MAST), multilocus sequence typing (MLST) and sequence typing for antimicrobial resistance (NG-STAR) were used to identify the sequence types. Genome analysis was conducted to analyze resistance genes, virulence factors, and evolutionary sources. Isolates with decreased ceftriaxone susceptibility have increased from 2.05% (2016) to 16.18% (2019). Six ceftriaxone-resistant isolates possessing 60.001 appeared in Guangdong Province, and were resistant to ceftriaxone, penicillin, tetracycline, ciprofloxacin and cefixime, but susceptible to azithromycin and spectinomycin. Single-nucleotide polymorphisms (SNPs) in the gene were the major cause of different NG-MAST types. ST1903 was the main NG-STAR genotype and only strain-ZH545 was ST7365, with molecular features consistent with the MICs. Furthermore, different MLSTs suggested diverse evolutionary sources. Genome analysis revealed a set of virulence factors along with the resistance genes " " and " ". Half of 60.001 strains were fully mixed with global FC428-related strains. Global FC428-related clones have disseminated across Guangdong, possibly causing decreased ceftriaxone susceptibility. Enhanced gonococcal surveillance will help elucidate the trajectory of transmission and curb further dissemination.
Background: After Neisseria gonorrhoeae FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate increased remarkably. Epidemiological investigations are greatly significant for the analysis of antimicrobial resistance (AMR) trends, molecular features and evolution. Objectives: To clarify the AMR trend from 2016–2019 and reveal the molecular characteristics and evolution of ceftriaxone-resistant penA 60.001 isolates. Methods: The minimum inhibitory concentrations (MICs) of antibiotics against 4113 isolates were detected by the agar dilution method. N. gonorrhoeae multiantigen sequence typing (NG-MAST), multilocus sequence typing (MLST) and N.gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) were used to identify the sequence types. Genome analysis was conducted to analyze resistance genes, virulence factors, and evolutionary sources. Results: Isolates with decreased ceftriaxone susceptibility have increased from 2.05% (2016) to 16.18% (2019). Six ceftriaxone-resistant isolates possessing penA 60.001 appeared in Guangdong Province, and were resistant to ceftriaxone, penicillin, tetracycline, ciprofloxacin and cefixime, but susceptible to azithromycin and spectinomycin. Single-nucleotide polymorphisms (SNPs) in the porB gene were the major cause of different NG-MAST types. ST1903 was the main NG-STAR genotype and only strain-ZH545 was ST7365, with molecular features consistent with the MICs. Furthermore, different MLSTs suggested diverse evolutionary sources. Genome analysis revealed a set of virulence factors along with the resistance genes “penA” and “blaTEM-1B”. Half of penA 60.001 strains were fully mixed with global FC428-related strains. Conclusions: Global FC428-related clones have disseminated across Guangdong, possibly causing decreased ceftriaxone susceptibility. Enhanced gonococcal surveillance will help elucidate the trajectory of transmission and curb further dissemination.
Background: After Neisseria gonorrhoeae FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate increased remarkably. Epidemiological investigations are greatly significant for the analysis of antimicrobial resistance (AMR) trends, molecular features and evolution. Objectives: To clarify the AMR trend from 2016–2019 and reveal the molecular characteristics and evolution of ceftriaxone-resistant penA 60.001 isolates. Methods: The minimum inhibitory concentrations (MICs) of antibiotics against 4113 isolates were detected by the agar dilution method. N. gonorrhoeae multiantigen sequence typing (NG-MAST), multilocus sequence typing (MLST) and N.gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) were used to identify the sequence types. Genome analysis was conducted to analyze resistance genes, virulence factors, and evolutionary sources. Results: Isolates with decreased ceftriaxone susceptibility have increased from 2.05% (2016) to 16.18% (2019). Six ceftriaxone-resistant isolates possessing penA 60.001 appeared in Guangdong Province, and were resistant to ceftriaxone, penicillin, tetracycline, ciprofloxacin and cefixime, but susceptible to azithromycin and spectinomycin. Single-nucleotide polymorphisms (SNPs) in the porB gene were the major cause of different NG-MAST types. ST1903 was the main NG-STAR genotype and only strain-ZH545 was ST7365, with molecular features consistent with the MICs. Furthermore, different MLSTs suggested diverse evolutionary sources. Genome analysis revealed a set of virulence factors along with the resistance genes “ penA ” and “ blaTEM-1B ”. Half of penA 60.001 strains were fully mixed with global FC428-related strains. Conclusions: Global FC428-related clones have disseminated across Guangdong, possibly causing decreased ceftriaxone susceptibility. Enhanced gonococcal surveillance will help elucidate the trajectory of transmission and curb further dissemination.
Background: After Neisseria gonorrhoeae FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate increased remarkably. Epidemiological investigations are greatly significant for the analysis of antimicrobial resistance (AMR) trends, molecular features and evolution. Objectives: To clarify the AMR trend from 2016-2019 and reveal the molecular characteristics and evolution of ceftriaxone-resistant penA 60.001 isolates. Methods: The minimum inhibitory concentrations (MICs) of antibiotics against 4113 isolates were detected by the agar dilution method. N. gonorrhoeae multiantigen sequence typing (NG-MAST), multilocus sequence typing (MLST) and N.gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) were used to identify the sequence types. Genome analysis was conducted to analyze resistance genes, virulence factors, and evolutionary sources. Results: Isolates with decreased ceftriaxone susceptibility have increased from 2.05% (2016) to 16.18% (2019). Six ceftriaxone-resistant isolates possessing penA 60.001 appeared in Guangdong Province, and were resistant to ceftriaxone, penicillin, tetracycline, ciprofloxacin and cefixime, but susceptible to azithromycin and spectinomycin. Single-nucleotide polymorphisms (SNPs) in the porB gene were the major cause of different NG-MAST types. ST1903 was the main NG-STAR genotype and only strain-ZH545 was ST7365, with molecular features consistent with the MICs. Furthermore, different MLSTs suggested diverse evolutionary sources. Genome analysis revealed a set of virulence factors along with the resistance genes "penA" and "blaTEM-1B". Half of penA 60.001 strains were fully mixed with global FC428-related strains. Conclusions: Global FC428-related clones have disseminated across Guangdong, possibly causing decreased ceftriaxone susceptibility. Enhanced gonococcal surveillance will help elucidate the trajectory of transmission and curb further dissemination.Background: After Neisseria gonorrhoeae FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate increased remarkably. Epidemiological investigations are greatly significant for the analysis of antimicrobial resistance (AMR) trends, molecular features and evolution. Objectives: To clarify the AMR trend from 2016-2019 and reveal the molecular characteristics and evolution of ceftriaxone-resistant penA 60.001 isolates. Methods: The minimum inhibitory concentrations (MICs) of antibiotics against 4113 isolates were detected by the agar dilution method. N. gonorrhoeae multiantigen sequence typing (NG-MAST), multilocus sequence typing (MLST) and N.gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) were used to identify the sequence types. Genome analysis was conducted to analyze resistance genes, virulence factors, and evolutionary sources. Results: Isolates with decreased ceftriaxone susceptibility have increased from 2.05% (2016) to 16.18% (2019). Six ceftriaxone-resistant isolates possessing penA 60.001 appeared in Guangdong Province, and were resistant to ceftriaxone, penicillin, tetracycline, ciprofloxacin and cefixime, but susceptible to azithromycin and spectinomycin. Single-nucleotide polymorphisms (SNPs) in the porB gene were the major cause of different NG-MAST types. ST1903 was the main NG-STAR genotype and only strain-ZH545 was ST7365, with molecular features consistent with the MICs. Furthermore, different MLSTs suggested diverse evolutionary sources. Genome analysis revealed a set of virulence factors along with the resistance genes "penA" and "blaTEM-1B". Half of penA 60.001 strains were fully mixed with global FC428-related strains. Conclusions: Global FC428-related clones have disseminated across Guangdong, possibly causing decreased ceftriaxone susceptibility. Enhanced gonococcal surveillance will help elucidate the trajectory of transmission and curb further dissemination.
Author Yu, Yuqi
Wu, Xingzhong
Xie, Qinghui
Liao, Yiwen
Tang, Sanmei
Zheng, Heping
Lin, Xiaomian
Qin, Xiaolin
Chen, Wentao
Feng, Zhanjin
Author_xml – sequence: 1
  givenname: Xiaomian
  orcidid: 0000-0002-7780-0458
  surname: Lin
  fullname: Lin, Xiaomian
  organization: Southern Medical University
– sequence: 2
  givenname: Wentao
  surname: Chen
  fullname: Chen, Wentao
  organization: Southern Medical University
– sequence: 3
  givenname: Qinghui
  surname: Xie
  fullname: Xie, Qinghui
  organization: Southern Medical University
– sequence: 4
  givenname: Yuqi
  surname: Yu
  fullname: Yu, Yuqi
  organization: Southern Medical University
– sequence: 5
  givenname: Yiwen
  surname: Liao
  fullname: Liao, Yiwen
  organization: Southern Medical University
– sequence: 6
  givenname: Zhanjin
  surname: Feng
  fullname: Feng, Zhanjin
  organization: Southern Medical University
– sequence: 7
  givenname: Xiaolin
  surname: Qin
  fullname: Qin, Xiaolin
  organization: Southern Medical University
– sequence: 8
  givenname: Xingzhong
  surname: Wu
  fullname: Wu, Xingzhong
  organization: Southern Medical University
– sequence: 9
  givenname: Sanmei
  surname: Tang
  fullname: Tang, Sanmei
  organization: Southern Medical University
– sequence: 10
  givenname: Heping
  surname: Zheng
  fullname: Zheng, Heping
  email: zhengheping@smu.edu.cn
  organization: Southern Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34994305$$D View this record in MEDLINE/PubMed
BookMark eNqFUtFuFCEUnZgaW2s_QUPiS02cCswww8TE2LS6Nmm0ifpMGOYyS8PACmx1v9Dfkum2pu2D8nCBe889HOA8LXacd1AUzwk-IpjjNzQP0jJyRDGdAyEN4Y-KvTlfzoWdO-vd4iDGS5xHi5ua1E-K3aruurrCbK_4fWpihMk4mYx3SLoBjeD8BHkp7SaaiLxGSzMuSwtXYJECnYKRv7KgMkCuJ-kSWoE7Rg0-wpigzzBTZgwavfMhLD1IQDEFaVxEOvgJpSWgxVq6cfBuRIsMU14pafOhyfTGJ6MiiuuoYDXvrUkbdBH8GOSUlR0uTsvF8deLV69RvnpT5tA9Kx5raSMc3Mz7xfePH76dfCrPvyzOTo7PS8UamkrCWc96qnvoWtW0Q0-x7GQPQInWrG4Up5o3qtegqaoqaNnQ95qzqqVDxRte7RdnW97By0uxCmaSYSO8NOI64cMoZMjyLQhMmKKMcqZ6XlNGuqrPGgY-AOVtw5rM9W7LtVr3EwwKXH4je4_0fsWZpRj9leBtV-OGZILDG4Lgf6whJjGZ_GbWSgd-HQXNrqAVq3GVoS8fQC_9OuQvzqi25rhiTUsz6sVdRX-l3PolA95uASr4GANooUy6ts78vVYQLGaDiluDitmg4saguZs96L494H9977d9xmkfJvnTBzuIJDfWBx2kUyaK6t8UfwC6CfzW
CitedBy_id crossref_primary_10_1093_jac_dkad281
crossref_primary_10_1128_spectrum_03952_22
crossref_primary_10_1097_IM9_0000000000000158
crossref_primary_10_1097_IM9_0000000000000113
crossref_primary_10_1128_spectrum_02449_23
crossref_primary_10_1128_spectrum_03507_23
crossref_primary_10_3390_antibiotics13050468
crossref_primary_10_1016_S1473_3099_24_00001_X
crossref_primary_10_1080_22221751_2023_2249124
crossref_primary_10_1093_jac_dkac202
crossref_primary_10_3389_fphar_2023_1291885
crossref_primary_10_1093_jacamr_dlad139
crossref_primary_10_1186_s12941_023_00587_x
crossref_primary_10_3389_fmolb_2023_1258834
crossref_primary_10_1093_jac_dkad193
crossref_primary_10_2147_IDR_S408896
crossref_primary_10_2807_1560_7917_ES_2022_27_50_2200899
crossref_primary_10_2807_1560_7917_ES_2023_28_10_2300125
crossref_primary_10_3390_ijms23073550
crossref_primary_10_3390_microorganisms10122388
crossref_primary_10_1016_j_ijantimicag_2024_107101
crossref_primary_10_1097_JD9_0000000000000247
crossref_primary_10_1128_spectrum_02335_22
crossref_primary_10_1093_infdis_jiad258
crossref_primary_10_1080_22221751_2024_2440489
crossref_primary_10_1128_aac_02294_21
crossref_primary_10_1038_s41579_024_01023_3
crossref_primary_10_3390_ijms231810499
crossref_primary_10_1093_jac_dkac158
crossref_primary_10_1093_jac_dkae217
crossref_primary_10_1093_jac_dkad168
crossref_primary_10_1093_jac_dkae297
crossref_primary_10_3390_ijms25115781
Cites_doi 10.1371/journal.pone.0220339
10.1016/S1473-3099(17)30753-3
10.3201/eid2507.190172
10.1186/s13073-021-00858-2
10.1093/jac/dkaa196
10.1093/bioinformatics/btz305
10.1097/OLQ.0000000000000859
10.1093/nar/gku1196
10.1128/AAC.00149-15
10.1016/S1369-5274(99)00008-9
10.1111/j.1365-2958.1994.tb00489.x
10.1128/AAC.46.3.769-777.2002
10.1128/mSphere.00977-20
10.1038/s41467-021-24072-1
10.1111/j.1462-5822.2009.01308.x
10.1093/molbev/msz189
10.1007/s40265-021-01530-0
10.1177/0956462420949126
10.1371/journal.pmed.1002499
10.15585/mmwr.mm6950a6
10.1074/jbc.RA119.009942
10.1073/pnas.92.17.7986
10.1038/s41572-019-0128-6
10.1128/mBio.00187-11
10.1099/mgen.0.000056
10.1016/j.ijantimicag.2019.08.015
10.1111/j.1365-2958.2006.05079.x
10.2471/BLT.18.228486
10.1128/AAC.00325-11
10.1111/mmi.12002
10.1128/IAI.00319-16
10.1093/jac/dkaa526
10.1093/jac/dkaa123
10.1093/jac/dkz530
ContentType Journal Article
Copyright 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2022
2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2022 The Author(s)
Copyright_xml – notice: 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2022
– notice: 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2022 The Author(s)
DBID 0YH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1080/22221751.2021.2011618
DatabaseName Taylor & Francis Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database ProQuest
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE


Publicly Available Content Database
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 0YH
  name: Taylor & Francis Open Access
  url: https://www.tandfonline.com
  sourceTypes: Publisher
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
DocumentTitleAlternate Emerging Microbes & Infections
EISSN 2222-1751
EndPage 350
ExternalDocumentID oai_doaj_org_article_015c25285cb8425193b562d8de287656
PMC8794061
34994305
10_1080_22221751_2021_2011618
2011618
Genre Research Article
Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: Medical Science and Technology Research Foundation of Guangdong Province
  grantid: B2020149
  funderid: 10.13039/501100009330
– fundername: "Overseas Famous Teacher" Project of Guangdong Provincial Science and Technology Department
  grantid: 2020A1414010136
  funderid: 10.13039/501100007162
– fundername: Guangdong Traditional Chinese Medicine Research Project
  grantid: 202105291302207230
GroupedDBID 0YH
3V.
53G
5VS
7X7
88E
8FI
8FJ
AAHBH
ABUWG
ACGFS
ADBBV
ADRAZ
AENEX
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BENPR
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBS
ECGQY
EMOBN
FYUFA
GROUPED_DOAJ
HMCUK
HYE
KQ8
M1P
M48
M4Z
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
TDBHL
UKHRP
AAYXX
CITATION
PHGZM
PHGZT
BCNDV
CGR
CUY
CVF
ECM
EIF
EJD
NPM
PJZUB
PPXIY
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c562t-185b5b2fbe97c67db20a9abee21ff546c82f86cbfef2c33e75dbbf85372d38683
IEDL.DBID 0YH
ISSN 2222-1751
IngestDate Wed Aug 27 01:27:11 EDT 2025
Thu Aug 21 14:14:43 EDT 2025
Fri Jul 11 02:51:45 EDT 2025
Fri Jul 25 20:41:37 EDT 2025
Mon Jul 21 05:55:15 EDT 2025
Tue Jul 01 04:46:42 EDT 2025
Thu Apr 24 22:58:17 EDT 2025
Wed Dec 25 09:03:42 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords N. gonorrhoeae
ceftriaxone-resistant
epidemiological investigation
penA 60.001
Language English
License open-access: http://creativecommons.org/licenses/by-nc/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c562t-185b5b2fbe97c67db20a9abee21ff546c82f86cbfef2c33e75dbbf85372d38683
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Xiaomian Lin, Wentao Chen and Qinghui Xie contributed equally to this work.
Supplemental data for this article can be accessed https://doi.org/10.1080/22221751.2021.2011618
ORCID 0000-0002-7780-0458
OpenAccessLink https://www.tandfonline.com/doi/abs/10.1080/22221751.2021.2011618
PMID 34994305
PQID 2748035672
PQPubID 2041957
PageCount 7
ParticipantIDs crossref_citationtrail_10_1080_22221751_2021_2011618
proquest_journals_2748035672
pubmed_primary_34994305
crossref_primary_10_1080_22221751_2021_2011618
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8794061
proquest_miscellaneous_2618235403
informaworld_taylorfrancis_310_1080_22221751_2021_2011618
doaj_primary_oai_doaj_org_article_015c25285cb8425193b562d8de287656
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-Dec
PublicationDateYYYYMMDD 2022-12-01
PublicationDate_xml – month: 12
  year: 2022
  text: 2022-Dec
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: London
PublicationTitle Emerging microbes & infections
PublicationTitleAlternate Emerg Microbes Infect
PublicationYear 2022
Publisher Taylor & Francis
Taylor & Francis Ltd
Taylor & Francis Group
Publisher_xml – name: Taylor & Francis
– name: Taylor & Francis Ltd
– name: Taylor & Francis Group
References e_1_3_5_29_1
e_1_3_5_28_1
e_1_3_5_27_1
e_1_3_5_26_1
e_1_3_5_25_1
e_1_3_5_24_1
e_1_3_5_23_1
e_1_3_5_22_1
e_1_3_5_3_1
e_1_3_5_2_1
e_1_3_5_9_1
e_1_3_5_21_1
e_1_3_5_8_1
e_1_3_5_5_1
e_1_3_5_4_1
e_1_3_5_7_1
e_1_3_5_6_1
e_1_3_5_18_1
e_1_3_5_17_1
e_1_3_5_16_1
e_1_3_5_15_1
e_1_3_5_13_1
e_1_3_5_14_1
e_1_3_5_35_1
e_1_3_5_11_1
e_1_3_5_34_1
e_1_3_5_12_1
e_1_3_5_33_1
e_1_3_5_19_1
Unemo M (e_1_3_5_20_1) 2020; 2020
e_1_3_5_32_1
e_1_3_5_10_1
e_1_3_5_31_1
e_1_3_5_30_1
References_xml – ident: e_1_3_5_22_1
  doi: 10.1371/journal.pone.0220339
– ident: e_1_3_5_3_1
  doi: 10.1016/S1473-3099(17)30753-3
– ident: e_1_3_5_6_1
  doi: 10.3201/eid2507.190172
– ident: e_1_3_5_17_1
  doi: 10.1186/s13073-021-00858-2
– ident: e_1_3_5_25_1
  doi: 10.1093/jac/dkaa196
– ident: e_1_3_5_14_1
  doi: 10.1093/bioinformatics/btz305
– ident: e_1_3_5_26_1
  doi: 10.1097/OLQ.0000000000000859
– ident: e_1_3_5_12_1
  doi: 10.1093/nar/gku1196
– ident: e_1_3_5_31_1
  doi: 10.1128/AAC.00149-15
– ident: e_1_3_5_23_1
  doi: 10.1016/S1369-5274(99)00008-9
– ident: e_1_3_5_30_1
  doi: 10.1111/j.1365-2958.1994.tb00489.x
– ident: e_1_3_5_21_1
  doi: 10.1128/AAC.46.3.769-777.2002
– ident: e_1_3_5_33_1
  doi: 10.1128/mSphere.00977-20
– ident: e_1_3_5_11_1
  doi: 10.1038/s41467-021-24072-1
– ident: e_1_3_5_32_1
  doi: 10.1111/j.1462-5822.2009.01308.x
– ident: e_1_3_5_15_1
  doi: 10.1093/molbev/msz189
– ident: e_1_3_5_5_1
  doi: 10.1007/s40265-021-01530-0
– volume: 2020
  start-page: 956462420949126
  year: 2020
  ident: e_1_3_5_20_1
  article-title: European guideline for the diagnosis and treatment of gonorrhoea in adults
  publication-title: Int J STD AIDS
  doi: 10.1177/0956462420949126
– ident: e_1_3_5_18_1
  doi: 10.1371/journal.pmed.1002499
– ident: e_1_3_5_19_1
  doi: 10.15585/mmwr.mm6950a6
– ident: e_1_3_5_24_1
  doi: 10.1074/jbc.RA119.009942
– ident: e_1_3_5_29_1
  doi: 10.1073/pnas.92.17.7986
– ident: e_1_3_5_16_1
  doi: 10.1038/s41572-019-0128-6
– ident: e_1_3_5_28_1
  doi: 10.1128/mBio.00187-11
– ident: e_1_3_5_13_1
  doi: 10.1099/mgen.0.000056
– ident: e_1_3_5_10_1
  doi: 10.1016/j.ijantimicag.2019.08.015
– ident: e_1_3_5_27_1
  doi: 10.1111/j.1365-2958.2006.05079.x
– ident: e_1_3_5_2_1
  doi: 10.2471/BLT.18.228486
– ident: e_1_3_5_4_1
  doi: 10.1128/AAC.00325-11
– ident: e_1_3_5_34_1
  doi: 10.1111/mmi.12002
– ident: e_1_3_5_35_1
  doi: 10.1128/IAI.00319-16
– ident: e_1_3_5_9_1
  doi: 10.1093/jac/dkaa526
– ident: e_1_3_5_8_1
  doi: 10.1093/jac/dkaa123
– ident: e_1_3_5_7_1
  doi: 10.1093/jac/dkz530
SSID ssj0000706414
Score 2.4292583
Snippet Background: After Neisseria gonorrhoeae FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate...
After FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate increased remarkably....
Background: After Neisseria gonorrhoeae FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
informaworld
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 344
SubjectTerms Anti-Bacterial Agents - pharmacology
Antibiotics
Antimicrobial Agents
Azithromycin - pharmacology
Ceftriaxone - pharmacology
ceftriaxone-resistant
China - epidemiology
Ciprofloxacin - pharmacology
Drug resistance
Drug Resistance, Bacterial
epidemiological investigation
Genome, Bacterial
Genomes
Gonorrhea
Gonorrhea - drug therapy
Gonorrhea - microbiology
Humans
Microbial Sensitivity Tests
Molecular Epidemiology
Multilocus Sequence Typing
N. gonorrhoeae
Neisseria gonorrhoeae - classification
Neisseria gonorrhoeae - drug effects
Neisseria gonorrhoeae - genetics
Neisseria gonorrhoeae - isolation & purification
penA 60.001
Penicillin
Spectinomycin - pharmacology
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NatwwEBYlp0Ip_a_btKjQQwt1s5ZkSz5um2ZDoSHQBnIz1t8mkMhh7YXmlnfoU_U1-iSdkb2LNxT20pMXW8IeaXbmkzTzDSFvuc1rbpxKleYsFcqLtBS1TK3VshaCGx9zYb4dFYcn4utpfjoq9YUxYT09cD9we-CuDMuZyo3GEyPAGxpctlXWAdYHMILWF3zeaDEVbbAEV5uJVcqOmuyBHwT0neOSkGWRurPAQh8jZxQ5-28xlv4Ld94Onxz5o4MH5P4AJOm0F-AhuePCI3Kv34WjfXLRY_J7H4_bMdoFx5_WwVIkZb108LMnI6GNp0hZnF5g9BA1zmMdj59NcCksxBFcho5euTClBUanZfTIxRP885rOm9AsFmeNqx1tY6mJlmK2CgVMSUH1wtw2YU5n0AysLugCvBQzVBpkhqbtso0RNTE495oe93Fi8GXvZvvpbPr9-P0HCuNX_Ln5BZfyCTk5-PLj82E6FG9IDcxPlwIO0LlmXrtSmkJazSZ1WWvnWOZ9LgqjmFeF0d55Zjh3MrdaewAPklmuCsWfkp0Awj4n1Bi4M7ETaXwmtPIqK0CfYOGbgYA-1wkRq1mszMBsjlJfVNlAgLqa_AonvxomPyEf192uemqPbR0-oYqsGyMzd7wB-loN-lpt09eElGMFq7q4MeP7KioV3_IBuyttrAZT01ZMCjXheSFZQt6sH4ORwJOfOrhmCW2gM8MdPp6QZ73yrqXgsOZF3reEyA213hBz80k4P4tE5AqMOeDBF_9jXF6SuwwzS2Kk0C7Z6RZL9wrwXqdfx7_2Xz3xTvY
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3NjtMwELZguSAhxD-BBRmJA0iYbWzHcU-osGxXSKxWgpV6i-K_7kqLU5pWghvvwFPxGjwJM05a2hViT40SW7UzY-eb8cw3hDwXrqiF9ZppIziTOkg2lHXJnDNlLaWwIeXCfDxShyfyw6SY9A63tg-rXO2JaaN2jUUf-R5YT3ogClXyN7OvDKtG4elqX0LjKrmG1GWo1eWkXPtYQJ2VzOUqcUcP9uBrCBi8QMOQ54nAU2G5j41PUmLuv8Bb-i_0eTGIcuOrdHCL3OzhJB118r9Nrvh4h9zofHG0SzG6S37t46E7xrygFGgdHUVq1i8eLjtKEtoEisTF7BxjiKj1Aat5fGuiZ2COI8SMCzrzcUQVxqjl9Minc_yzmk6b2Mznp42vPW1TwYmWYs4KBWRJQQHj1DVxSsfQDPZe0Aj4U8xTaZAfmrbLNsXVpBDd7_S4ixaDkb0Y77Px6NPxy1cU3p_6_eMn_AzvkZOD95_fHbK-hAOzAKwWDNCAKQwPxg9Lq0pn-KAe1sZ7nodQSGU1D1pZE3zgVghfFs6YABCi5E5opcV9shNhsg8JtRbuDNygtCGXRgedK9AqMH9zmGAoTEbkSoqV7fnNcdbnVd7ToK6EX6Hwq174GXm97jbrCD4u6_AWVWTdGPm5041mPq365V4ByLK84LqwBs85ASUbeB9OOw8WKkDojAw3FaxaJPdM6GqpVOKSAeyutLHqN5y2-rs8MvJs_Ri2Cjz_qaNvltAGOnP084mMPOiUdz0LAZYvsr9lpNxS661pbj-JZ6eJjlzDlg6o8NH_h_WYXOeYOZIigXbJzmK-9E8Azy3M07Ro_wAXrEg2
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9RAEF9qfRFE_DZaZQUfFEy97G6ymweR09orQktBD_oWsl_XwplokoP2L_TfcmaTHL1S6YNvR7LLZXZmd3-zO_MbQt5wm5bcOBUrzVkslBdxLkoZW6tlKQQ3PuTCHB5lB3Px7SQ92SIjocIwgO21rh3Wk5o3y93z3xefYMJ_HCLkPsAWB8A6RW-PJYGVM0vULXIbNieJRQ0OB8QfFmcJe3Aixlyef_Xe2KUCmf8VKtPrAOnVuMpLG9X-fXJvQJh02pvEA7Llqofkbn88R_uso0fkzx7ew2MYDCqGlpWlyNb608HPnqWE1p4il3G8xLAiapzHAh_ndeVi8NARdVYdhaGa0gzD1hJ65MLV_llJF3VVN81p7UpH21CDoqWYxkIBbFKwyWph62pBZ9AMlmMwEvhTTF2pkTKatqs2hNqEqN0LetwHkMGXvZ3txbPp9-N37ymMXwYzL8kfk_n-1x9fDuKhpkNsAGl1McADnWrmtculyaTVbFLmpXaOJd6nIjOKeZUZ7Z1nhnMnU6u1B0whmeUqU_wJ2a5A1GeEGgNPJnYijU-EVl4lGZgZ-MMJiOdTHREx6rAwA-E5yrwskoEXdVR9gaovBtVHZHfd7VfP-HFTh89oIOvGSNgdHtTNohjmfwGoy7CUqdRovPgE2KxhPKyyDlxWwNQRyS-bV9GF8xrfF1cp-A0fsDPaYjFOoIJJoSY8zSSLyOv1a1g78EKorFy9gjbQmeHBH4_I095011JwcIWRDi4icsOoN8TcfFOdnQZ-cgVrPMDE5_8h0gtyh2GeSYgb2iHbXbNyLwH9dfpVmM9_AULpUiw
  priority: 102
  providerName: Scholars Portal
Title Dissemination and genome analysis of high-level ceftriaxone-resistant penA 60.001 Neisseria gonorrhoeae strains from the Guangdong Gonococcal antibiotics susceptibility Programme (GD-GASP), 2016-2019
URI https://www.tandfonline.com/doi/abs/10.1080/22221751.2021.2011618
https://www.ncbi.nlm.nih.gov/pubmed/34994305
https://www.proquest.com/docview/2748035672
https://www.proquest.com/docview/2618235403
https://pubmed.ncbi.nlm.nih.gov/PMC8794061
https://doaj.org/article/015c25285cb8425193b562d8de287656
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1db9MwFLVge0FCiO8FRmUkHkAikNiO7T52bGuFtKoCJo2nKHbsbtJIpiaV4Bfyt7jXSap1Au2Bl6hKbDU3vrbPtc89JuQNL7OCW6djbTiLhfYiHotCxWVpVCEEtz7kwpzM5exUfD7LBjZh09MqMYb2nVBEGKuxcxemGRhxH2FKAyCdYXTH0qDCKVN9l-zCTJzgIQbJ99lmmQU8WopUDLk7_6q9NSsF8f4b0qV_A6A3eZTXJqbjh-RBjyjppHOBR-SOqx6T-91yHO2yjJ6Q34e47460F2wICqZTVGf94eBnp0pCa09Ruzi-RBoRtc7jgR4_68rFEJEjyqxaeuWqCZVIU0vp3IWt_IuCLuuqXq3Oa1c42oQzJxqKaSsUwCUFH6yWZV0t6RSKwfALTgF_iqkqNUpE02bdBGpNYOn-oouOMAZv9nZ6GE8nXxfv3lP4fhJ6Wjp-Sk6Pj759msX9GQ6xBWTVxgAHTGaYN26srFSlYUkxLoxzLPU-E9Jq5rW0xjvPLOdOZaUxHjCEYiXXUvNnZKcCU_cItRbuJGWirE-F0V6nEtwK4t8UzPOZiYgY2jC3vcA52nyZp70O6tD0OTZ93jd9RD5sql11Ch-3VThAB9kURoHucKNeLfO-v-eAsizLmM6swY1OgMkGvkepSwchKmDoiIyvu1fehvUZ3x2mkvNbXmB_8MW8H3GanCmhE55JxSLyevMYxgrcACoqV6-hDFRmuNDHI_K8c92NFRxCX5R_i4jacuotM7efVBfnQY9cw5gOsPDFf5j0ktxjmFcSeEL7ZKddrd0rQHutGYX-DFd1pkZk9-BovvgyCisncD0R-g9y3U_b
linkProvider Taylor & Francis
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEF2V8gASQtwxFFgkkEDC1N71ZfOAUCA0Kb2oEq2UN9d7SysVO8SJoG_8A__Bf_AbfAkzazskFaJPfXJk7zq7ntm57M6cIeQZ13HOlRG-kJz5kbCR34ny1NdapnkUcWVdLszObjI4iD4O4-EK-dnmwmBYZSsTnaDWpcI98nXwnkTA4yRlb8dffKwahaerbQmNmi22zOlXcNmqN5s9oO9zxjY-7L8f-E1VAV-Brp_6oKBkLJmVppOqJNWSBXknl8aw0No4SpRgViRKWmOZ4tyksZbSglZLmeYiERzee4lcBsUboLOXDtP5ng4snyQKozZRSATroH3B5o_REWWhAwxNsLzIggp0lQLO4KT-y9o9G7S5oAU3bpDrjflKuzW_3SQrprhFrtV7f7ROabpNfvXwkB9jbJDqNC80RSjYzwZ-1hAotLQUgZL9E4xZospYrB7yrSyMD-4_mrTFlI5N0aUJxsSFdNe4uIHjnI7KopxMjkqTG1q5AhcVxRwZCpYsBYYvRrosRrQPzUDWAwfCn2JeTIl41LSaVS6Ox4UEn9K9OjoNRvai3_P73U97L19R-H7J7-8_4NK5Qw4uhLh3yWoBk71PqFJwJ9BBqmwYSWFFmAAXg7sdwgRtLD0StVTMVIOnjrM-ycIGdrUlfobEzxrie-T1vNu4BhQ5r8M7ZJF5Y8QDdzfKyShrxEsGRp1iMROxkniuCla5hO-hhTbgEYPJ7pHOIoNlU7cdZOvaLRk_ZwBrLTdmjYCrsr_L0SNP549BNOF5U16YcgZtoDPDfUXukXs1885nwcHTRrQ5j6RLbL00zeUnxfGRgz8XoELACn3w_2E9IVcG-zvb2fbm7tZDcpVh1oqLQlojq9PJzDwCW3IqH7sFTMnhRUuMPxq1huE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bi9QwFA66gggi3q2uGsEHBbtOc2vmcXTcGW_DgC7oU2luswtrO0xnQH-hf8tz0nbYWZR98K20Ce1pTpLvJN_5Qshz7mTJrdepNpylQgeRDkWZp86ZvBSC2xBzYT7P1PRIfPgmezZh09EqMYYOrVBEHKuxcy9d6Blxr2FKAyAtMbpjWVThVJm-TK5ImHvx9IbB9-l2mQU8WolM9Lk7_6q9MytF8f5z0qV_A6DneZRnJqbDm-RGhyjpqHWBW-SSr26T6-1yHG2zjO6Q32Pcd0faCzYEBdMpqrP-8HDZqpLQOlDULk5PkUZErQ94oMfPuvIpROSIMqs1XfpqRBXS1DI683Er_6Ski7qqV6vj2peeNvHMiYZi2goFcEnBB6uFq6sFnUAxGH7BKeClmKpSo0Q0bTZNpNZElu4vOm8JY_BlLybjdDL6Mn_5isL_U9DTsuFdcnT47uvbadqd4ZBaQFbrFOCAkYYF44e5VbkzbFAOS-M9y0KQQlnNglbWBB-Y5dzn0hkTAEPkzHGtNL9H9iow9QGh1sKdgRvkNmTC6KAzBW4F8W8G5gVpEiL6NixsJ3CONp8WWaeD2jd9gU1fdE2fkINttWWr8HFRhTfoINvCKNAdb9SrRdH19wJQlmWSaWkNbnQCTDbwP5x2HkJUwNAJGZ51r2Id12dCe5hKwS_4gP3eF4tuxGkKlgs94FLlLCHPto9hrMANoLLy9QbKQGWGC308Ifdb191awSH0Rfm3hOQ7Tr1j5u6T6uQ46pFrGNMBFj78D5Oekqvz8WHx6f3s4yNyjWGKSaQM7ZO99WrjHwPwW5snsWv_ASJwTig
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dissemination+and+genome+analysis+of+high-level+ceftriaxone-resistant+penA+60.001+Neisseria+gonorrhoeae+strains+from+the+Guangdong+Gonococcal+antibiotics+susceptibility+Programme+%28GD-GASP%29%2C+2016-2019&rft.jtitle=Emerging+microbes+%26+infections&rft.au=Lin%2C+Xiaomian&rft.au=Chen%2C+Wentao&rft.au=Xie%2C+Qinghui&rft.au=Yu%2C+Yuqi&rft.date=2022-12-01&rft.pub=Taylor+%26+Francis&rft.eissn=2222-1751&rft.volume=11&rft.issue=1&rft.spage=344&rft.epage=350&rft_id=info:doi/10.1080%2F22221751.2021.2011618&rft.externalDBID=0YH&rft.externalDocID=2011618
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2222-1751&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2222-1751&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2222-1751&client=summon